Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections
- 20 September 2007
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 59 (4) , 407-414
- https://doi.org/10.1016/j.diagmicrobio.2007.06.008
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Trial Design for Mold-Active Agents: Time to Break the Mold--Aspergillosis in Neutropenic AdultsClinical Infectious Diseases, 2007
- Design Issues in Studies Evaluating Diagnostic Tests for AspergillosisClinical Infectious Diseases, 2005
- Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in HumansClinical Infectious Diseases, 2005
- Emerging Fungal DiseasesClinical Infectious Diseases, 2005
- Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections: Results of the Collaborative Exchange of Antifungal Research (CLEAR), an Industry-Supported Patient RegistryClinical Infectious Diseases, 2005
- Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent CasesThe Journal of Infectious Diseases, 2005
- A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999Journal of Antimicrobial Chemotherapy, 2004
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer PatientsJournal of Clinical Oncology, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002